For example, Ki-67 expression was considered as a marker based on the spatial marked point pattern in Chervoneva et al. (2021) and based on quantiles of marginal CSIs distribution in Yi et al. (2023b), and results for predicting progression-free survival in breast cancer were very similar with and without considering spatial distribution of Ki-67 CSIs. Here, MKI67 is linked to breast carcinoma.